Ticker: TSHA

Company: Taysha Gene Therapies, Inc.

Person: Sean P Nolan, director, officer

Transaction date: Jan. 23, 2026

Reporting date: Jan. 27, 2026

Average share price: 4.717525842078372

Sold 178101.0 shares for 840196.07